GT Biopharma developing treatment for coronavirus

You are here: Home > Biotech > Current Article

GT Biopharma developing treatment for coronavirus

By Staff Report / Tuesday, March 10th, 2020 / Comments Off on GT Biopharma developing treatment for coronavirus

Westlake Village drug developer GT Biopharma announced a collaboration with the U.S.-based subsidiary of a Chinese company to produce and test its TriKE therapeutic platform to treat patients infected with the novel coronavirus. Cytovance Biologics, a subsidiary of Shenzhen Hepalink Pharmaceutical, will manufacture GT Biopharma’s drug for preclinical evaluation and could later scale up production…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.